This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Management of inï¬ammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
Preprint
in English
| SciELO Preprints
| ID: pps-70
Responsible library:
BR1.1
ABSTRACT
The world is ï¬ghting the COVID-19 outbreak and health workers, including inï¬ammatory bowel diseases specialists, have been challenged to address the speciï¬c clinical issues of their patients. We hereby summarize the current literature in the management of inï¬ammatory bowel disease (IBD) patients during the COVID-19 pandemic era that support the rearrangement of our IBD unit and the clinical advice provided to our patients
Full text:
Available
Collection:
Preprints
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 3 Human resources for health
Database:
SciELO Preprints
Type of study:
Practice guideline
Country/Region as subject:
South America
/
Brazil
Language:
English
Year:
2020
Document type:
Preprint
